You are here:
Editorial: In Vitro Toxicogenomics (TGx) in Hazard and Risk Assessment
Citation:
Beal, M. AND L. Everett. Editorial: In Vitro Toxicogenomics (TGx) in Hazard and Risk Assessment. Frontiers in Toxicology. Frontiers, Lausanne, Switzerland, 5:1284932, (2023). https://doi.org/10.3389/ftox.2023.1284932
Impact/Purpose:
This editorial will serve as a summary of publications accepted under the research topic “in vitro Toxicogenomics (TGx) in Hazard and Risk Assessment” at Frontiers in Toxicology: https://www.frontiersin.org/research-topics/34633/in-vitro-toxicogenomics-tgx-in-hazard-and-risk-assessment
Description:
Toxicogenomics (TGx) involves the application of transcriptomics to study how cells and organisms respond to environmental and chemical exposures through by measuring changes in gene expression. TGx technologies have proven to be valuable tools in human health and environmental risk assessment. Specifically, TGx data provides a wealth of mechanistic insight to support a weight-of-evidence approach when establishing links between exposure and adverse outcomes. This Research Topic presents a collection of articles highlighting recent in vitro TGx advancements to establish the utility of both TGx methods and data for hazard and risk assessment.
URLs/Downloads:
DOI: Editorial: In Vitro Toxicogenomics (TGx) in Hazard and Risk Assessment![Exit EPA's Web Site](images/exitingepa.gif)
https://pubmed.ncbi.nlm.nih.gov/37736263/
![Exit EPA's Web Site](images/exitingepa.gif)